CMI vs PSIX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 28, 2026

CMI

33.3
AI Score
VS
CMI Wins

PSIX

31.6
AI Score

Investment Advisor Scores

CMI

Sep 28, 2026
33score
Recommendation
AVOID NEW MONEY

PSIX

Sep 28, 2026
32score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric CMI PSIX Winner
Forward P/E 15.3846 32.6797 CMI
PEG Ratio 1.0562 0.8222 PSIX
Revenue Growth 9.4% -20.5% CMI
Earnings Growth 4.7% -67.1% CMI
Tradestie Score 33.3/100 31.6/100 CMI
Profit Margin 7.8% 10.0% PSIX
Beta 1.00 1.00 Tie
Implied Volatility N/A N/A Tie
AI Recommendation AVOID NEW MONEY AVOID NEW MONEY Tie

Relative Price Performance (Last 90 Days)

CMI 1M: -4.1% · 3M: -22.1% PSIX 1M: +25.7% · 3M: +22.3%

Current Technical Phase

CMI

Markdown
Sell / avoid

Price below a falling SMA50 (slope -8.7%), weak momentum, RSI 39

RSI (14): 39.4 · Price: $528.32

PSIX

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (11.0% over 20 days), RSI 57

RSI (14): 56.9 · Price: $44.85

Fundamentals Snapshot

Metric CMI PSIX
Market Cap — —
Forward P/E 15.7 13.8
Trailing P/E 26.4 15.6
Revenue (TTM) — —
Revenue Growth 0.1% -0.2%
Gross Margin 0.3% 0.2%
Operating Margin 0.1% 0.2%
EPS 19.59 2.91
Dividend Yield 0.02% —

Frequently Asked Questions

Based on our detailed analysis, CMI is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.